Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47dd8d710fb14d1ece910b6ace242349 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e19741e967ed6c909c17813b4f9ef63e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
filingDate |
2007-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_974c077ef30106d520b3231222aa588f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63401ba5dfeea54189bcf6c3346371fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6427fd4ebd1145753f30748b8c891a7d |
publicationDate |
2010-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010010080-A1 |
titleOfInvention |
Use of tylvalosin as antiviral agent |
abstract |
The invention relates to the use of a macrolide antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110134-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10905135-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11627741-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357046-B2 |
priorityDate |
2006-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |